This trial has been completed.

Condition tobacco use disorder
Treatment behavior therapy
Phase phase 2/phase 3
Sponsor National Institute on Drug Abuse (NIDA)
Start date January 2002
End date April 2006
Trial size 90 participants
Trial identifier NCT00064922, NIDA-13638-3, R01-13638-3


The purpose of this study is to examine the effects of incentive programs for the treatment of nicotine dependence in women who have problems with substance dependence.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Primary purpose treatment

Eligibility Criteria

Female participants from 15 years up to 99 years old.

Inclusion Criteria: - Pregnant and or post-partum with at least one child under 1 year old living with them, or non-pregnant, non-post-partum females or previous participant in this study protocol - Nicotine Dependent as confirmed by DSM-IV checklist - Current cigarette smoker - Breath CO reading of at least 8 ppm at the time of the initial study screening - Current client with the Shields for Families (Shields) treatment programs Exclusion Criteria: - Non-smoker

Additional Information

Official title Incentive Programs for Female Substance Abusers Who Smoke
Principal investigator Leslie Amass, Ph.D.
Description This study will determine the influence of voucher-based CM on reducing smoking (and other drug) use during pregnancy or in post-partum women with children under 1 year of age living with them, or in non-pregnant females who smoke. We are targeting smoking cessation since cigarette use is so prevalent in our service. We will compare a control group to two different voucher-based contingent-reinforcement procedures: one that targets smoking abstinence alone vs. one that offers additional incentives for negative BAL and urinalysis results.
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by National Institute on Drug Abuse (NIDA).